Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

REST THERAPEUTICS : revenue, balance sheet and financial ratios

REST THERAPEUTICS is a French company founded 5 years ago, specialized in the sector Activités spécialisées, scientifiques et techniques diverses. Based in PARIS (75006), this company of category PME shows in 2022 a net income positive of 362 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - REST THERAPEUTICS (SIREN 889773941)
Indicator 2022 2021
Revenue N/C N/C
Net income 361 988 € 82 075 €
EBITDA N/C 60 501 €
Net margin N/C N/C

Revenue and income statement

In 2022, REST THERAPEUTICS generates positive net income of 362 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2022: 82 k€ -> 362 k€.

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

361 988 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 46%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

46.332%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

65.104%

Asset age ratio (2022) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

80.7%

Solvency indicators evolution
REST THERAPEUTICS

Sector positioning

Debt ratio
46.33 2022
2021
2022
Q1: 0.0
Med: 6.3
Q3: 58.55
Average

In 2022, the debt ratio of REST THERAPEUTICS (46.33) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
65.1% 2022
2021
2022
Q1: 4.97%
Med: 34.11%
Q3: 65.07%
Excellent +8 pts over 2 years

In 2022, the financial autonomy of REST THERAPEUTICS (65.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
3.99 years 2021
2021
Q1: 0.0 years
Med: 0.0 years
Q3: 0.69 years
Average

In 2021, the repayment capacity of REST THERAPEUTICS (3.99) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 544.01. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

544.009

Liquidity indicators evolution
REST THERAPEUTICS

Sector positioning

Liquidity ratio
544.01 2022
2021
2022
Q1: 139.16
Med: 254.07
Q3: 507.77
Excellent +24 pts over 2 years

In 2022, the liquidity ratio of REST THERAPEUTICS (544.01) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
23.18x 2021
2021
Q1: 0.0x
Med: 0.0x
Q3: 0.38x
Excellent

In 2021, the interest coverage of REST THERAPEUTICS (23.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2022) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2022) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2022) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2022) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
REST THERAPEUTICS

Positioning of REST THERAPEUTICS in its sector

Comparison with sector Activités spécialisées, scientifiques et techniques diverses

Valuation estimate

Based on 98 transactions of similar company sales (all years), the value of REST THERAPEUTICS is estimated at 1 756 926 € (range 353 744€ - 2 955 395€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2022
98 tx
353k€ 1756k€ 2955k€
1 756 926 € Range: 353 744€ - 2 955 395€
NAF 5 all-time

Valuation method used

Net Income Multiple
361 988 € × 4.9x = 1 756 927 €
Range: 353 744€ - 2 955 395€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 98 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités spécialisées, scientifiques et techniques diverses)

Compare REST THERAPEUTICS with other companies in the same sector:

Voir toutes les statistiques du secteur Activités spécialisées, scientifiques et techniques diverses

Frequently asked questions about REST THERAPEUTICS

What is the revenue of REST THERAPEUTICS ?

The revenue of REST THERAPEUTICS is not publicly disclosed (confidential accounts filed with INPI).

Is REST THERAPEUTICS profitable?

Yes, REST THERAPEUTICS generated a net profit of 362 k€ in 2022.

Where is the headquarters of REST THERAPEUTICS ?

The headquarters of REST THERAPEUTICS is located in PARIS (75006), in the department Paris.

Where to find the tax return of REST THERAPEUTICS ?

The tax return of REST THERAPEUTICS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does REST THERAPEUTICS operate?

REST THERAPEUTICS operates in the sector Activités spécialisées, scientifiques et techniques diverses (NAF code 74.90B). See the 'Sector positioning' section above to compare the company with its competitors.